BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
L. De Smet, W. Ceelen, J. P. Remon, C. Vervaet. Optimization of Drug Delivery Systems for Intraperitoneal Therapy to Extend the Residence Time of the Chemotherapeutic AgentThe Scientific World Journal 2013; 2013: 1 doi: 10.1155/2013/720858
2
Yaw-Bin Huang, Chi-Te Huang, Hsin-Yeh Tsou, Li-Tse Fu, Yaw-Sya Fu, Yi-Hung Tsai, Pao-Chu Wu. The transport effect of submicron emulsions on 5-flurouracil topical applicationJournal of Microencapsulation 2013; 30(5): 425 doi: 10.3109/02652048.2012.746748
3
Andrea M. Stringer, Rachel J. Gibson, Richard M. Logan, Joanne M. Bowen, Ann S. J. Yeoh, Juliette Hamilton, Dorothy M. K. Keefe. Gastrointestinal Microflora and Mucins May Play a Critical Role in the Development of 5-Fluorouracil-Induced Gastrointestinal MucositisExperimental Biology and Medicine 2009; 234(4): 430 doi: 10.3181/0810-RM-301
4
Jianle Zhou, Liang Li, Hailu Zhang, Jiangping Xu, Dandan Huang, Ningbo Gong, Weili Han, Xuemei Yang, Zhengzheng Zhou. Crystal structures, dissolution and pharmacokinetic study on a novel phosphodiesterase-4 inhibitor chlorbipram cocrystalsInternational Journal of Pharmaceutics 2020; 576: 118984 doi: 10.1016/j.ijpharm.2019.118984
5
Guo-Ping Wang, Yong-Song Guan, Xin-Rong Jin, Sha-Sha Jiang, Ze-Jun Lu, Yang Wu, Yang Li, Mei Li, Feng Luo. Development of novel 5-fluorouracil carrier erythrocyte with pharmacokinetics and potent antitumor activity in mice bearing malignant ascitesJournal of Gastroenterology and Hepatology 2010; 25(5): 985 doi: 10.1111/j.1440-1746.2009.06155.x
6
Shuhei Fukuno, Katsuhito Nagai, Keita Kasahara, Yuki Mizobata, Sachiko Omotani, Yasutoshi Hatsuda, Michiaki Myotoku, Hiroki Konishi. Altered tolbutamide pharmacokinetics by a decrease in hepatic expression of CYP2C6/11 in rats pretreated with 5-fluorouracilXenobiotica 2018; 48(1): 53 doi: 10.1080/00498254.2017.1278808